在26S蛋白酶体中,PSMC6和α环之间的一致性与阿尔茨海默氏症相关

相关实验视频

Updated: Jul 3, 2025

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

Jing Xiong¹, Xinping Pang², Xianghu Song¹

¹College of Computer Science, Sichuan Normal University, Chengdu, China.

Frontiers in molecular neuroscience

|February 15, 2024

概括

阿尔茨海默病涉及蛋白质酶功能障碍. 这项研究发现,尽管数量减少,但蛋白质酶变得更加活跃,以对抗异常的蛋白质积累并保持大脑健康,这表明蛋白质酶具有保护作用.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
计算生物学计算生物学

背景情况:

阿尔茨海默病 (AD) 的特点是蛋白质的异常积累和蛋白质毒性.
26S蛋白酶体是泛素蛋白蛋白酶体系统 (UPS) 的一部分,它会降解异常蛋白质.
了解蛋白酶在阿尔茨海默氏症病原发生中的作用对于治疗开发至关重要.

研究的目的:

研究蛋白质酶功能与阿尔茨海默病进展之间的关系.
分析蛋白酶子单元的表达和协调,包括枢纽基因PSMC6和α环基因.
探索蛋白酶活性作为AD风险生物标志物的潜力.

主要方法:

微阵列数据的生物信息学分析.
支持矢量机器学习.
多变量统计分析. 多变量统计分析.
和矩阵决定因素的计算,以评估蛋白质酶体系统的乱和协调.

主要成果:

随着阿尔茨海默氏症的进展,蛋白质组数量会减少,这是由于蛋白质组蛋白质 (下调的枢纽基因) 的表达受损.
现有的蛋白质体表现出增加的活性和效率,增强了全球协调,减少了系统性疾病.
PSMC6和α环子单元的协同下调与AD风险的更高概率相关.

结论:

蛋白质酶活性在AD中增加,以抵消蛋白质毒性并维持中枢神经系统的蛋白质稳定.
减少的蛋白酶体数量和改变的子单元协调 (和决定性变化) 与AD进展有关.
活跃的蛋白酶作为抗阿尔茨海默病的防御者,具有减少的和决定性指示保护机制.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.一个决定性的决定因素.进入的过程中,蛋白质酶体蛋白质组是什么支持矢量机器的支持矢量机器

更多相关视频

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Published on: December 17, 2016

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain

Published on: October 24, 2017

相关概念视频

The Proteasome Structure

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

Protein Complex Assembly

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...